The Michael J. Fox Foundation (MJFF)-sponsored Parkinson’s Progression Markers Initiative (PPMI) announced recently a partnership with the New York Stem Cell Foundation Research Institute to create cell lines from PPMI patients’ skin samples to study the biology of Parkinson’s on a cellular level.
MJFF Contributing Editor Dave Iverson reports on the new technology NYSCF will use and the current state of stem cell research in Parkinson’s disease. He speaks with Olle Lindvall, MD, PhD, chairman of the Division of Neurology at the University Hospital in Lund, Sweden and MJFF scientific advisor, and Brian Fiske, PhD, vice president of research programs at MJFF.
LISTEN TO THE PODCAST ON THE FUTURE OF STEM CELLS & PARKINSON’S